Skip to main content

Namenda XR (Memantine) Shopper Approved

Prescription Prescription Required FormationFormulation: Extended Release Capsule

Namenda XR

(Brand Option)

Select the prescribed dosage

Select the quantity to see the price.

  *  
Prescription Prescription Required FormationFormulation: Extended Release Capsule

Memantine

(Generic Alternative)

Select the prescribed dosage

Select the quantity to see the price.

  *  
delivery

* This price includes a dispensing fee, medical review fee, and packing fee.

delivery

Shipped and delivered directly to your doorstep

Namenda XR is a prescription medication used to treat moderate to severe dementia associated with Alzheimer’s disease.

It contains memantine hydrochloride, an active ingredient that helps regulate the activity of certain chemical messengers in the brain involved in learning, memory, and communication between nerve cells.

Namenda XR belongs to a class of medications called N-methyl-D-aspartate (NMDA) receptor antagonists. These medications work by regulating the effects of glutamate, a neurotransmitter that helps nerve cells communicate with one another.

Glutamate plays an important role in memory formation, learning, and normal brain function. However, excessive glutamate activity may contribute to nerve cell dysfunction and damage in people with Alzheimer’s disease.

Namenda XR helps regulate this activity, potentially improving or maintaining certain aspects of memory, thinking, awareness, and daily functioning.

Namenda XR is an extended-release medication, meaning it gradually releases memantine throughout the day. It is generally taken once daily to provide continuous treatment.

Namenda XR helps manage symptoms of moderate to severe Alzheimer’s disease, but it does not cure the disease, reverse existing brain damage, or stop its progression.

Treatment of Moderate to Severe Alzheimer’s Disease

Namenda XR is approved for the treatment of moderate to severe dementia associated with Alzheimer’s disease.

Alzheimer’s disease is a progressive neurological condition that affects memory, thinking, behavior, and the ability to perform everyday activities.

It develops when changes in the brain gradually damage nerve cells and disrupt communication between them.

As the disease progresses, patients may experience increasing difficulty remembering information, recognizing familiar people, making decisions, or completing routine tasks.

During the moderate stages of Alzheimer’s disease, patients may require assistance with daily activities, such as getting dressed, preparing meals, or managing medications.

In the severe stages, patients may experience significant memory loss, communication difficulties, and increased dependence on caregivers.

Namenda XR helps regulate glutamate activity in the brain, which may improve certain symptoms or slow the worsening of symptoms for some patients over a period of time.

However, the response varies between individuals, and not everyone experiences noticeable improvement.

Namenda XR may help support cognitive function and daily activities in patients with moderate to severe Alzheimer’s disease, but it does not prevent the underlying disease from progressing.

Management of Memory and Cognitive Symptoms

Namenda XR may help manage certain cognitive symptoms associated with Alzheimer’s disease.

Cognitive function refers to the brain’s ability to remember information, think clearly, communicate, solve problems, and understand the surrounding environment.

As Alzheimer’s disease progresses, damage to nerve cells can interfere with these abilities.

Patients may have difficulty remembering recent conversations, following instructions, identifying familiar objects, or recognizing people.

Some individuals may also experience confusion, reduced attention, or difficulty making decisions.

Namenda XR works by regulating the activity of NMDA receptors in the brain.

These receptors are involved in communication between nerve cells and play an important role in learning and memory.

By reducing excessive NMDA receptor activity, Namenda XR may help improve or stabilize certain cognitive abilities.

However, its benefits are generally modest, and the medication does not restore memories that have already been lost.

Namenda XR may help maintain certain aspects of memory, attention, and thinking, although its effects differ from person to person.

Support for Daily Functioning

Namenda XR may also help some patients maintain their ability to perform everyday activities.

As Alzheimer’s disease advances, tasks that were previously simple may become increasingly difficult.

Patients may need assistance with dressing, bathing, eating, preparing meals, or following daily routines.

These difficulties can develop because changes in the brain affect memory, concentration, judgment, and the ability to coordinate activities.

Namenda XR may help reduce some of the functional difficulties associated with moderate to severe Alzheimer’s disease.

For certain patients, treatment may help preserve their ability to participate in daily activities for a period of time.

Caregivers may also notice changes in the patient’s awareness, responsiveness, or ability to complete familiar tasks.

However, improvement is not guaranteed, and patients may continue to need increasing support as the disease progresses.

Namenda XR may help support everyday functioning, but it does not eliminate the need for appropriate care, supervision, and assistance.

Use in Other Types of Dementia

Namenda XR is specifically approved for treating moderate to severe dementia caused by Alzheimer’s disease.

Dementia is a general term describing a decline in memory, thinking, reasoning, or other cognitive abilities that interferes with everyday life.

Although Alzheimer’s disease is the most common cause, dementia may also develop because of other neurological conditions.

These include vascular dementia, Lewy body dementia, and dementia associated with Parkinson’s disease.

Some healthcare providers may consider memantine for selected patients with other forms of dementia. However, these uses are generally considered off-label, meaning they are not specifically approved indications for Namenda XR.

The effectiveness of memantine varies depending on the type of dementia, and evidence is not equally strong for every condition.

Your healthcare provider will determine whether the medication is appropriate based on the underlying diagnosis, symptom severity, and individual treatment needs.

Namenda XR is FDA-approved for moderate to severe Alzheimer’s dementia, not for all types of dementia. 

How Does Namenda XR Work?

Namenda XR contains memantine, a medication that helps regulate the activity of glutamate in the brain.

Glutamate is a neurotransmitter, which means it is a chemical messenger that allows nerve cells to communicate.

Under normal conditions, glutamate plays an important role in learning, memory formation, and other cognitive functions.

However, excessive or prolonged stimulation of certain glutamate receptors may contribute to nerve cell dysfunction.

Namenda XR works by blocking excessive activity at NMDA receptors without completely preventing normal glutamate signaling.

Regulates NMDA Receptor Activity

NMDA receptors are specialized structures on nerve cells that respond to glutamate.

They help regulate communication between nerve cells and are involved in memory and learning.

When these receptors are overstimulated, excessive calcium may enter nerve cells and contribute to cellular damage.

Namenda XR helps limit this excessive stimulation.

Supports Communication Between Nerve Cells

By regulating abnormal NMDA receptor activity, Namenda XR may help support the brain’s remaining communication pathways.

This can provide modest benefits in cognitive function and everyday activities for some patients.

However, the exact way memantine produces its clinical benefits in Alzheimer’s disease is not completely understood.

Provides Extended-Release Medication Delivery

Namenda XR gradually releases memantine throughout the day.

This allows the medication to be taken once daily rather than following the twice-daily maintenance schedule commonly used with immediate-release memantine.

The extended-release formulation helps provide consistent medication exposure when taken as prescribed.

Namenda XR works by regulating excessive glutamate activity at NMDA receptors, helping manage certain symptoms of Alzheimer’s disease.

How Long Does Namenda XR Take to Work?

Namenda XR begins acting on NMDA receptors after treatment starts, but noticeable changes in symptoms may take several weeks or longer.

Treatment usually begins with a low dose that is gradually increased to improve tolerability.

Your healthcare provider will monitor your response and determine whether dosage adjustments are necessary.

Some patients may show improvements in awareness, attention, or daily functioning.

For others, the benefit may be maintaining certain abilities for a period rather than producing an obvious improvement.

Your healthcare provider may assess treatment effectiveness through cognitive evaluations and discussions with family members or caregivers.

Continue taking Namenda XR as prescribed, even if improvements are not immediately noticeable.

Important Information About Namenda XR

Namenda XR is available as extended-release capsules in strengths of 7 mg, 14 mg, 21 mg, and 28 mg.

It is generally taken once daily, with or without food.

The capsules may be swallowed whole or opened and sprinkled onto applesauce, according to the product instructions. The entire contents must be swallowed without chewing.

Possible side effects include dizziness, headache, and diarrhea.

Patients with severe kidney impairment may require a lower dosage because memantine is primarily eliminated through the kidneys.

Namenda XR may be prescribed alongside certain other Alzheimer’s medications, including donepezil, when appropriate.

Namenda XR is a treatment for symptoms of moderate to severe Alzheimer’s disease, not a cure. Regular follow-up appointments help your healthcare provider evaluate its benefits, monitor side effects, and determine whether treatment should continue. 

Namenda XR is a prescription medication used to treat moderate to severe dementia associated with Alzheimer’s disease.

It contains memantine hydrochloride, an active ingredient that helps regulate certain chemical signals in the brain involved in learning, memory, and cognitive function.

Namenda XR is available as an extended-release capsule and is usually taken once daily, with or without food.

The extended-release formulation gradually releases memantine throughout the day, helping maintain consistent medication levels.

Swallow the capsule whole with a glass of water. Do not crush, chew, or divide the contents into separate doses because doing so may interfere with the medication’s extended-release properties.

If you have difficulty swallowing capsules, you may open a Namenda XR capsule and sprinkle all its contents onto a small amount of applesauce.

Swallow the mixture immediately without chewing. Do not prepare or store the mixture for later use.

Your healthcare provider will determine the appropriate dosage based on your medical condition, kidney function, response to treatment, and tolerance of the medication.

The usual recommended maintenance dosage is 28 mg once daily for adults with normal kidney function. However, treatment generally begins at a lower dose that is gradually increased.

Take Namenda XR exactly as prescribed. Do not increase your dosage, take extra capsules, or change your treatment schedule without consulting your healthcare provider.

How to Take Namenda XR Correctly

Namenda XR capsules are taken by mouth, usually once daily.

The medication can be taken with or without food, depending on your preference and how well you tolerate it.

If you can swallow capsules comfortably, take your prescribed dose with a glass of water.

Do not crush or chew the capsule or the extended-release beads inside it.

If swallowing capsules is difficult, the contents may be sprinkled onto applesauce according to the manufacturer’s instructions.

Take Namenda XR at approximately the same time each day to maintain a consistent treatment routine.

Caregivers may help patients remember their medication, particularly when Alzheimer’s disease affects memory or the ability to follow daily schedules.

Follow the instructions on your prescription label carefully, and ask your healthcare provider or pharmacist if you are unsure how to administer the medication.

How to Take Namenda XR With Applesauce

Namenda XR capsules may be opened and their contents sprinkled onto applesauce for patients who have difficulty swallowing capsules.

This method allows the medication to be taken without swallowing the capsule shell.

To prepare the medication:

  1. Prepare the Applesauce: Place a small amount of applesauce in a clean spoon or container.
  2. Open the Capsule: Carefully open one prescribed Namenda XR capsule.
  3. Sprinkle the Contents: Empty the entire contents of the capsule onto the applesauce.
  4. Swallow Immediately: Swallow the full mixture without chewing the extended-release beads.
  5. Do Not Save the Mixture: Prepare the medication immediately before use and discard any mixture that cannot be administered as directed.

Make sure the entire prescribed dose is taken.

Do not crush the beads, mix them into hot food, or divide the contents into multiple doses.

This administration method is intended for applesauce, as described in the product instructions.

If you use applesauce to administer Namenda XR, swallow the entire mixture immediately without chewing.

What Is the Recommended Dosage of Namenda XR?

The recommended dosage of Namenda XR depends on kidney function, treatment response, and the patient’s ability to tolerate the medication.

For adults with normal kidney function, the usual starting dose is 7 mg once daily.

Your healthcare provider may gradually increase the dosage in increments of 7 mg.

A common dosage adjustment schedule is:

Treatment period Daily dose
Week 1 7 mg once daily
Week 2 14 mg once daily
Week 3 21 mg once daily
Week 4 onward 28 mg once daily

This schedule is an example of standard dose titration, not an instruction to increase the dose automatically.

Dosage increases should occur at intervals of at least one week and only when the previous dose is well tolerated.

The recommended maintenance dosage is 28 mg once daily for adults with normal kidney function.

Patients with severe kidney impairment generally require a lower maximum dosage of 14 mg once daily.

Do not increase your Namenda XR dosage unless your healthcare provider specifically instructs you to do so.

Why Does Namenda XR Treatment Start With a Low Dose?

Namenda XR is usually started at a low dose to help the body adjust to the medication.

This process is called dose titration.

Dose titration involves gradually increasing the amount of medication until the recommended or most appropriate dosage is reached.

Starting with a lower dose may reduce the likelihood of side effects such as dizziness, headache, or digestive discomfort.

Your healthcare provider will assess your response before recommending a higher dose.

Not every patient will require or tolerate the maximum recommended dosage.

Some patients may remain on a lower dose because of kidney impairment or unwanted side effects.

Follow your healthcare provider’s dosage adjustment schedule carefully and do not increase the dose more quickly than recommended.

Can I Take Namenda XR With Food?

Yes. Namenda XR may be taken with or without food.

Food does not significantly affect the overall amount of medication absorbed into the body.

You may take Namenda XR with breakfast, lunch, or another meal that fits your daily routine.

If you experience mild stomach discomfort, taking the medication with food may make it easier to tolerate.

However, it is not necessary to take Namenda XR with a meal unless your healthcare provider recommends doing so.

If you have difficulty swallowing the capsule, you may open it and sprinkle the entire contents onto applesauce.

Take Namenda XR consistently according to your prescribed schedule, regardless of whether you choose to take it with food.

When Is the Best Time to Take Namenda XR?

Namenda XR is usually taken once daily at approximately the same time each day.

There is no specific time of day that is best for every patient.

Some patients prefer taking Namenda XR in the morning because it is easier to remember.

Others may follow a different schedule based on their routine and healthcare provider’s recommendations.

Because Alzheimer’s disease can affect memory and judgment, caregivers may need to assist with medication administration.

A daily medication reminder, calendar, or supervised routine may help prevent missed or repeated doses.

It is important to make sure that the medication has not already been taken before administering another capsule.

Take Namenda XR at approximately the same time each day to help maintain consistent treatment and reduce the risk of missed doses.

What Should I Do If I Miss a Dose of Namenda XR?

If you forget to take one dose of Namenda XR, skip the missed dose and take your next dose at the regularly scheduled time.

Do not take two doses together or take an additional capsule to make up for the missed medication.

Taking extra Namenda XR may increase the risk of side effects, including dizziness, confusion, headache, or other unwanted reactions.

If you have missed several consecutive days of treatment, contact your healthcare provider before restarting.

You may need to restart at a lower dose and gradually increase it again.

This is important because the body may no longer tolerate the previous maintenance dosage after a prolonged interruption.

Never double your Namenda XR dose. If treatment has been interrupted for several days, consult your healthcare provider before restarting. 

Can I Switch From Immediate-Release Memantine to Namenda XR?

Patients taking immediate-release memantine may sometimes be switched to Namenda XR.

Both medications contain memantine, but they release the active ingredient differently.

Immediate-release memantine tablets are generally taken twice daily at the usual maintenance dosage.

Namenda XR releases medication gradually and is usually taken once daily.

For some adults taking immediate-release memantine 10 mg twice daily, the recommended conversion is Namenda XR 28 mg once daily, starting the day after the final immediate-release dose.

However, patients with severe kidney impairment require a different conversion schedule and lower dosage.

The two formulations should not be considered interchangeable on a milligram-for-milligram basis.

Your healthcare provider will determine the appropriate conversion based on your current treatment and kidney function.

Do not switch between immediate-release memantine and Namenda XR without consulting your healthcare provider or pharmacist. 

Why Does Kidney Function Matter When Taking Namenda XR?

Namenda XR is primarily eliminated from the body through the kidneys.

The kidneys help remove waste products and certain medications from the bloodstream.

When kidney function is significantly reduced, memantine may remain in the body longer than expected.

This can increase medication exposure and the risk of side effects.

Patients with severe kidney impairment generally require a lower maintenance dosage.

Under U.S. prescribing information, the recommended maximum dosage for adults with severe renal impairment is 14 mg once daily.

Your healthcare provider may recommend blood tests to assess kidney function before or during treatment.

Tell your healthcare provider if you have kidney disease or reduced kidney function. Do not change your Namenda XR dosage without medical guidance. 

How Long Should I Continue Taking Namenda XR?

Namenda XR is generally used as an ongoing treatment for moderate to severe Alzheimer’s dementia.

The length of treatment depends on your symptoms, response to medication, and overall health.

Some patients may experience modest improvements in memory, attention, or daily functioning.

For others, treatment may help maintain certain abilities for a period without producing obvious improvements.

However, Namenda XR does not cure Alzheimer’s disease or stop its underlying progression.

Your healthcare provider will regularly reassess whether the medication continues to provide meaningful benefits.

Family members and caregivers may help by reporting changes in memory, awareness, communication, and daily activities.

Do not stop taking Namenda XR simply because symptoms appear unchanged.

Continue using Namenda XR for as long as your healthcare provider recommends, and attend regular follow-up appointments to evaluate treatment effectiveness.

Important Information When Taking Namenda XR

Namenda XR should be taken once daily according to your prescribed treatment schedule.

Swallow the capsules whole or sprinkle their entire contents onto applesauce if swallowing is difficult.

Do not crush, chew, or divide the extended-release beads.

Possible side effects include dizziness, headache, diarrhea, and other changes in how you feel.

Dizziness may increase the risk of falls, especially in older adults or patients with balance difficulties.

Tell your healthcare provider if you experience worsening confusion, significant dizziness, or new behavioral changes.

Patients with severe kidney impairment may require a reduced dosage.

Caregivers should help monitor medication use to prevent accidental missed or duplicate doses.

Do not increase your dose, take two doses together, or switch medication formulations without medical guidance.

Regular follow-up appointments are important to assess cognitive symptoms, daily functioning, kidney health, and the overall benefits and risks of treatment.

Common Side Effects of Namenda XR (Memantine):

  • Aggression
  • Confusion
  • Constipation
  • Cough
  • Depression
  • Diarrhea
  • Dizziness
  • Headache
  • Nausea
  • Pain anywhere in your body, especially your back
  • Sleepiness
  • Vomiting
  • Weight gain

Serious Side Effects of Namenda XR (Memantine):

  • Blurred vision
  • Difficulty breathing
  • Hallucination (seeing things or hearing voices that do not exist)
  • Hives
  • Pounding in your neck or ears
  • Seizures
  • Severe headache
  • Shortness of breath
  • Swelling of your face, lips, tongue, or throat
  • Unusual changes in mood or behavior

Namenda XR (Memantine) is available in the following forms and strength:

Namenda XR: Extended Release Capsule

  • 7 mg
  • 14 mg
  • 21 mg
  • 28 mg

Memantine: Extended Release Capsule

  • 21 mg

Kidney Problems and Namenda XR

Namenda XR should be used with caution in patients with kidney disease or reduced kidney function.

The kidneys help remove waste products and certain medications from the bloodstream.

Namenda XR contains memantine, which is primarily eliminated from the body through the kidneys.

When kidney function is reduced, the medication may remain in the bloodstream longer than expected.

This can increase the amount of memantine in the body and raise the risk of side effects, including dizziness, confusion, headache, and excessive sleepiness.

Patients with severe kidney impairment generally require a lower dosage.

Under U.S. prescribing information, the recommended maximum dosage for patients with severe renal impairment is 14 mg once daily.

Your healthcare provider may recommend blood tests to evaluate kidney function before starting treatment or adjusting your dosage.

Tell your healthcare provider if you have kidney disease or reduced kidney function before taking Namenda XR. Do not adjust your dosage without medical guidance.

Seizure Disorders and Epilepsy

Patients with a history of seizures or epilepsy should use Namenda XR under careful medical supervision.

A seizure occurs when abnormal electrical activity in the brain causes sudden changes in movement, awareness, sensation, or consciousness.

Symptoms may include involuntary shaking, muscle stiffness, confusion, or temporary loss of awareness.

Namenda XR works by regulating the activity of NMDA receptors, which are involved in communication between nerve cells.

Because these receptors influence brain activity, additional caution may be appropriate for patients with seizure disorders.

Memantine has not been systematically evaluated in patients with seizure disorders, although seizures have been reported during clinical studies.

Tell your healthcare provider if you have epilepsy, previously experienced seizures, or take medications that may lower the seizure threshold.

Your healthcare provider will review your medical history and determine whether additional monitoring is necessary.

Seek emergency medical attention if you experience a new seizure, a prolonged seizure, or repeated seizures without recovering between episodes.

Bladder Problems and Urinary Tract Obstruction

Tell your healthcare provider if you have bladder problems, difficulty urinating, or a history of urinary tract obstruction before taking Namenda XR.

The urinary tract includes the kidneys, ureters, bladder, and urethra.

These structures work together to produce, store, and remove urine from the body.

Urinary tract obstruction occurs when something interferes with the normal flow of urine.

Possible causes include an enlarged prostate, urinary stones, or certain bladder conditions.

Changes in urine flow or urine acidity may affect how quickly memantine is removed from the body.

In particular, conditions that make urine more alkaline can reduce the elimination of memantine and increase medication exposure.

Your healthcare provider may review your urinary symptoms, kidney function, and other medications before prescribing Namenda XR.

Contact your healthcare provider if you develop difficulty urinating, significant changes in urination, or new bladder symptoms during treatment.

Seek urgent medical attention if you are suddenly unable to urinate, particularly if you also experience severe lower abdominal pain.

Liver Problems and Namenda XR

Patients with liver disease should inform their healthcare provider before starting Namenda XR.

The liver helps process many medications and remove certain substances from the bloodstream.

Although memantine is primarily eliminated through the kidneys, a small amount undergoes metabolism in the liver.

Patients with mild or moderate liver impairment generally do not require routine dosage adjustments.

However, Namenda XR has not been adequately studied in patients with severe liver impairment.

For this reason, your healthcare provider may recommend additional caution when prescribing the medication to patients with advanced liver disease.

The appropriate treatment depends on your overall health, kidney function, and other medications.

Tell your healthcare provider if you have liver disease or impaired liver function before starting Namenda XR.

Pregnancy and Namenda XR

Tell your healthcare provider if you are pregnant, planning to become pregnant, or think you may be pregnant before taking Namenda XR.

There is limited information about the safety of memantine during human pregnancy.

Although animal studies have provided some information about potential developmental risks, these findings cannot fully predict how the medication may affect a developing baby.

Namenda XR is approved for moderate to severe dementia associated with Alzheimer’s disease and is not generally used during pregnancy.

If treatment is being considered during pregnancy, your healthcare provider will assess the potential benefits and risks.

Do not assume that a medication is safe during pregnancy simply because it is prescribed for a chronic medical condition.

Do not start or continue Namenda XR during pregnancy without discussing its safety with your healthcare provider.

Breastfeeding and Namenda XR

Consult your healthcare provider before taking Namenda XR if you are breastfeeding.

It is not known whether memantine passes into human breast milk or how exposure might affect a breastfed infant.

There is also limited information about the medication’s potential effects on milk production.

Because of these uncertainties, your healthcare provider will consider the importance of treatment, the health of your baby, and whether another medication is more appropriate.

If Namenda XR is necessary, your healthcare provider can discuss potential risks and recommend an appropriate feeding plan.

Ask your healthcare provider whether Namenda XR is suitable during breastfeeding before starting or continuing treatment.

Medication Interactions With Namenda XR

Namenda XR may interact with certain prescription medications, over-the-counter products, and supplements.

Some interactions may increase memantine levels in the bloodstream, while others may increase the risk of side effects.

For example, dextromethorphan, a medication found in certain cough suppressants, also affects NMDA receptors.

Combining Namenda XR with other NMDA receptor antagonists, such as dextromethorphan, amantadine, or ketamine, may increase the risk of unwanted neurological effects.

Other medications, including cimetidine and hydrochlorothiazide, may affect how memantine is processed or eliminated. However, these combinations do not always cause clinically significant interactions.

Certain medications or substances that make urine more alkaline may reduce the removal of memantine through the kidneys.

This can increase medication exposure and the risk of adverse effects.

Your healthcare provider may recommend additional monitoring or changes to your medication regimen.

Tell your healthcare provider and pharmacist about all medications, vitamins, and herbal supplements you take before starting Namenda XR. 

Dizziness, Drowsiness, and Driving

Namenda XR may cause dizziness, headache, or sleepiness in some patients.

These effects may interfere with activities that require balance, concentration, or coordination.

Dizziness is one of the more commonly reported side effects of Namenda XR.

Some patients may feel lightheaded, unsteady, or less alert than usual.

These symptoms may be more noticeable when treatment begins or after the dosage is increased.

Older adults and patients with Alzheimer’s disease may already have balance or mobility difficulties, which can increase the risk of falls.

Caregivers should watch for changes in walking ability, alertness, or coordination.

Patients who experience dizziness should stand up carefully and avoid moving too quickly.

Do not drive, operate heavy machinery, or perform potentially dangerous activities if Namenda XR causes dizziness, excessive sleepiness, or reduced alertness.

Contact your healthcare provider if these symptoms are persistent or severe.

Heart Disease and Cardiovascular Conditions

Tell your healthcare provider if you have heart disease, high blood pressure, or a history of stroke before taking Namenda XR.

Cardiovascular disease affects the heart and blood vessels and may increase the risk of serious health complications.

Although Namenda XR is not primarily a cardiovascular medication, changes in blood pressure and other heart-related events have been reported during memantine treatment.

Some patients may have existing medical conditions that require additional monitoring.

Your healthcare provider will consider your cardiovascular history, current medications, and overall health when deciding whether Namenda XR is appropriate.

Patients with Alzheimer’s disease may also have difficulty recognizing or explaining new symptoms.

For this reason, caregivers should report unusual dizziness, fainting, chest discomfort, or changes in physical functioning.

Tell your healthcare provider if you have a history of heart disease, stroke, abnormal heart rhythms, or other significant cardiovascular conditions before starting Namenda XR.

Restarting Namenda XR After Several Missed Doses

If you have stopped taking Namenda XR for several consecutive days, contact your healthcare provider before restarting treatment.

Namenda XR is usually started at a low dose and gradually increased to improve tolerability.

The usual starting dose is 7 mg once daily, with increases made at intervals of at least one week when appropriate.

This gradual adjustment allows your body to become accustomed to the medication.

If treatment has been interrupted for several days, restarting at your previous maintenance dose may increase the risk of side effects.

Your healthcare provider may recommend restarting at a lower dosage and gradually increasing it again.

The appropriate approach depends on how long treatment was interrupted, your previous dosage, and your medical condition.

Do not automatically restart Namenda XR at your previous dosage after missing several days of treatment. Contact your healthcare provider for instructions. 

High Blood Pressure (Hypertension)

Namenda XR may cause increased blood pressure in some patients, although this is not among its most common side effects.

High blood pressure, also called hypertension, occurs when the force of blood against artery walls remains consistently elevated.

Over time, uncontrolled hypertension can increase the risk of heart disease, stroke, and kidney damage.

Patients with existing hypertension should continue taking their prescribed blood pressure medications while using Namenda XR.

Your healthcare provider may recommend regular blood pressure measurements, particularly if your readings become higher than usual.

Caregivers may need to assist patients with monitoring because Alzheimer’s disease can make it difficult to follow daily health routines.

High blood pressure often causes no noticeable symptoms, so monitoring is important.

Contact your healthcare provider if your blood pressure readings become consistently elevated during Namenda XR treatment.

Seek emergency medical attention if severely elevated blood pressure is accompanied by chest pain, severe headache, difficulty breathing, or sudden neurological symptoms.

Overactive Thyroid (Hyperthyroidism)

Tell your healthcare provider if you have an overactive thyroid or a history of thyroid disease before taking Namenda XR.

An overactive thyroid, also called hyperthyroidism, occurs when the thyroid gland produces excessive amounts of thyroid hormones.

These hormones help regulate metabolism, body temperature, and heart rate.

Symptoms of hyperthyroidism may include rapid heartbeat, nervousness, sweating, unexplained weight loss, and difficulty sleeping.

Some symptoms associated with thyroid disorders can also affect concentration, memory, or mental alertness.

For this reason, thyroid function may be considered when evaluating cognitive symptoms.

However, hyperthyroidism is not an established specific contraindication or major warning for Namenda XR.

There is no clear evidence that memantine routinely worsens thyroid hormone production.

Nevertheless, your healthcare provider should be aware of existing thyroid conditions and any medications used to treat them.

Tell your healthcare provider if you have thyroid disease or take thyroid medication so your complete medical history can be considered during treatment.

Important Safety Reminders When Taking Namenda XR

Namenda XR is used to manage symptoms of moderate to severe Alzheimer’s dementia.

Although it may help support memory, thinking, and everyday functioning, it does not cure Alzheimer’s disease or stop its progression.

Patients with kidney disease, seizure disorders, significant urinary problems, or other serious medical conditions may require additional monitoring.

Caregivers should watch for dizziness, falls, changes in behavior, or unusual symptoms during treatment.

Namenda XR should be taken once daily according to the prescribed dosage.

Do not increase the dose, take extra capsules, or restart treatment after several missed days without appropriate medical guidance.

These precautions are not an exhaustive list of all possible warnings, interactions, or adverse effects associated with Namenda XR. Always follow your healthcare provider’s instructions and consult your pharmacist if you have questions about treatment.

How Long Does It Take for Namenda XR to Start Working?

Namenda XR may take several weeks to produce noticeable improvements in symptoms associated with Alzheimer’s disease. However, the time needed to experience benefits varies from person to person. Namenda XR contains memantine, which helps regulate the activity of glutamate, a chemical messenger involved in learning, memory, and communication between nerve cells. Treatment usually begins with a low dose that is gradually increased to help reduce the risk of side effects. Some patients may experience modest improvements in memory, attention, awareness, or their ability to perform everyday activities. For others, the benefits may be less noticeable. Treatment may help maintain certain abilities for a period rather than produce an obvious improvement. Your healthcare provider may evaluate your response through memory assessments, cognitive testing, and observations from family members or caregivers. Continue taking Namenda XR as prescribed, even if you do not notice immediate improvements. Contact your healthcare provider if your symptoms worsen or you have concerns about treatment effectiveness.

Can Namenda XR Be Used in Patients With Mild Dementia?

Namenda XR is specifically approved for the treatment of moderate to severe dementia associated with Alzheimer’s disease. It is not FDA-approved for mild Alzheimer’s dementia because its effectiveness in patients with milder symptoms has not been clearly established. Alzheimer’s disease is a progressive neurological condition that affects memory, thinking, behavior, and the ability to perform daily activities. During the early stages, patients may experience forgetfulness, difficulty finding words, or trouble remembering recent conversations. As the disease progresses, symptoms may become more noticeable and interfere with everyday functioning. Namenda XR is generally prescribed when Alzheimer’s disease has reached the moderate or severe stages. In certain circumstances, a healthcare provider may consider prescribing memantine for a patient with mild dementia. This is considered off-label use, meaning the medication is being used for a condition or stage of disease outside its approved indication. However, other medications and treatment approaches may be more appropriate for patients with mild Alzheimer’s disease. Namenda XR is approved for moderate to severe Alzheimer’s dementia. Its use in mild dementia should only be considered when a healthcare provider determines that it is appropriate.

Is Namenda XR the Same as Namenda?

Namenda XR and Namenda contain the same active ingredient, memantine hydrochloride, but they are different formulations. Both medications belong to a class of drugs called NMDA receptor antagonists, which help regulate excessive glutamate activity in the brain. The main difference is how the medication is released and how frequently it is taken. Namenda is an immediate-release formulation. It releases memantine more quickly and is generally taken twice daily at the usual maintenance dosage. Namenda XR is an extended-release formulation that gradually releases memantine throughout the day. It is usually taken once daily. The recommended maintenance dosage also differs between the two formulations. For adults with normal kidney function, the usual maintenance dosage of immediate-release Namenda is 10 mg twice daily, while Namenda XR is typically prescribed at 28 mg once daily. Although both medications contain memantine, they should not be considered interchangeable on a milligram-for-milligram basis. Your healthcare provider will determine the appropriate dosage if switching between formulations. Do not switch between Namenda and Namenda XR or change your dosage without consulting your healthcare provider.

Can Namenda XR Be Crushed or Chewed?

No. Namenda XR capsules and their extended-release contents should not be crushed or chewed. Namenda XR is designed to release memantine gradually throughout the day. Crushing or chewing the extended-release beads may interfere with how the medication is released and increase the risk of unwanted side effects. The capsules should generally be swallowed whole with a glass of water. However, patients who have difficulty swallowing capsules may open a Namenda XR capsule and sprinkle its entire contents onto a small amount of applesauce. The mixture must be swallowed immediately without chewing. Do not divide the capsule contents into smaller doses or prepare the applesauce mixture in advance. This administration method may be particularly helpful for patients with Alzheimer’s disease who experience swallowing difficulties. Caregivers should make sure that the entire prescribed dose is taken. Never crush or chew Namenda XR capsules or their contents. If swallowing the capsule is difficult, the entire contents may be sprinkled onto applesauce and swallowed immediately without chewing.

REVIEWS

Additional Information Book
Generic name:

Memantine

Formulation:

Extended Release Capsule

Strength(s):

7mg, 14mg, 21mg, 28mg

Quantities Available:

90

Why customers love Online Pharmacies Canada

Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.

Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.

How to Order

How much Namenda XR can I order at once from a Canadian pharmacy?

When ordering Namenda XR (memantine) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.

Here’s what you need to know:

Dosage and Quantity: Namenda XR is commonly prescribed in dosages of 7 mg, 14 mg, 21 mg, or 28 mg, taken once daily. For a 90-day supply, this means you would order 90 capsules of the prescribed dosage (90 days x 1 capsule per day).

Do you sell memantine?

Yes, we sell memantine on our website. You can enjoy low prices when you order through us. To purchase memantine, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.

Do you offer shipping of Namenda XR (memantine) to the United States?

Yes, we ship Namenda XR (memantine) to both the United States and Puerto Rico.

Discover Our Users' Stories!

Watch how Online Pharmacies Canada is helping customers save money on their medications.

Online Pharmacies Canada Customer Testimonial #4
Online Pharmacies Canada Customer Testimonial #1
Online Pharmacies Canada - Customer Testimonial #2

Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Namenda XR (Memantine). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Namenda XR (Memantine).